![[ Visit Client Website ]](images/banner.gif)
Oregon’s legalization of supervised psilocybin services in 2020 established the first statewide regulatory framework for psychedelic services in the United States. As of 2026, more than 18,000 sessions have been delivered, positioning Oregon as a natural policy experiment for the integration of emerging behavioral health interventions into community-based settings. For social work, this shift raises critical questions about how novel services are implemented outside traditional medical systems, how safety and eligibility are communicated to clients, and whether access is equitably distributed. Despite growing interest in psychedelic-assisted services, little is known about how licensed service centers operationalize regulatory requirements and engage prospective clients in real-world interactions. This study examines how service centers communicate safety, assess eligibility, and define their services, with implications for social work practice, policy, and equitable access to care.
Methods:
We conducted a two-stage mixed-methods assessment of all 22 licensed psilocybin service centers in Oregon (July–August 2025), designed to approximate the information pathway of prospective clients. In Stage 1, two researchers independently reviewed each center’s website using a standardized extraction tool to document safety screening practices (e.g., psychiatric history, medication interactions, suicidality) and service characteristics (e.g., cost, accessibility, stated indications). In Stage 2, three trained research assistants conducted mystery shopper calls portraying prospective clients with depression taking an antidepressant and disclosing either (1) a history of alcohol use disorder or (2) a family history of psychosis. Quantitative and qualitative data were integrated to examine how centers communicate risk, uncertainty, and eligibility in practice.
Results:
All 22 centers referenced Oregon Health Authority safety requirements online. Mystery shoppers reached 15 centers (68.2%), yielding 27 calls. Staff consistently communicated core safety considerations, including identifying active suicidal ideation and lithium use as contraindications. While depression (81.8%) and substance use concerns (68.2%) were frequently described online as reasons to pursue services, staff adopted a cautious and measured stance regarding safety and expected benefit. Regarding antidepressant use, 66.7% recommended continuing SSRIs while deferring to prescribing providers, whereas 33.3% expressed uncertainty about interactions with continued SSRI use. For callers with alcohol use disorder, 80% were informed that participation might be possible with clinical stability; for those with a family history of schizophrenia, 58.3% were told participation could be considered with further evaluation. Centers described challenges navigating a non-medical regulatory framework while engaging in preparation and integration practices resembling therapeutic care. Mean service cost was $1,900 (range: $850–$3,000), with no insurance coverage; 96% offered sliding scale options. Staff reported increasing demand from out-of-state and international clients.
Conclusions and Implications:
Findings suggest that Oregon service centers are largely implementing regulatory safety requirements with consistency and transparency while navigating areas of clinical uncertainty. However, high out-of-pocket costs and lack of insurance coverage may limit access, raising concerns about inequitable access to emerging behavioral health services. This study underscores the role of social work research in informing policy and practice that promote accessible, accountable care and advance the common good in rapidly evolving treatment landscapes.